BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Experts in dermatology, medical aesthetics, tissue engineering - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Experts in dermatology, medical aesthetics, tissue engineering
X-ORIGINAL-URL:https://www.rbcconsultants.com
X-WR-CALDESC:Events for Experts in dermatology, medical aesthetics, tissue engineering
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250902T190000
DTEND;TZID=America/New_York:20250902T200000
DTSTAMP:20260415T175209
CREATED:20250813T184158Z
LAST-MODIFIED:20250813T184254Z
UID:1395-1756839600-1756843200@www.rbcconsultants.com
SUMMARY:Explore EBGLYSS®(lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression
DESCRIPTION:Speaker: Jeffrey LaDuca\, MD Founder Reflections Dermatology and Psoriasis Center New York\, New York Dr. LaDuca earned his undergraduate degree in biology from LeMoyne College in Syracuse\, NY. After beginning his graduate studies at Penn State University\, Dr. LaDuca earned his PhD in physiology from Roswell Park Cancer Institute in Buffalo\, NY. Dr. LaDuca completed his medical degree at SUNY at Syracuse. After completing an internship in Internal Medicine in Syracuse\, Dr. LaDuca completed his residency in Dermatology at The University of Rochester. It was during these years that Dr. LaDuca became interested in psoriasis and inflammatory skin conditions and was involved in clinical trials for some of the first biologic agents. Dr. LaDuca is the founder and managing partner of Reflections Dermatology and Psoriasis Center with three offices open in central New York. He continues to contribute to peer-reviewed journals\, teach residents\, medical and PA/NP students and lecture extensively about the use of biologics in dermatology. \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nPlease join us for our next IDEF Educational Series Webinar: Explore EBGLYSS®(lebrikizumab-lbkz): See How EBGLYSS Can Leave a Lasting Impression. Join us for “Explore EBGLYSS® (lebrikizumab-lbkz)”\, where Jeffrey LaDuca\, MD will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data\, safety\, dosing information\, and how to get patients started on EBGLYSS. \n  \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/explore-ebglysslebrikizumab-lbkz-see-how-ebglyss-can-leave-a-lasting-impression/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250819T190000
DTEND;TZID=America/New_York:20250819T200000
DTSTAMP:20260415T175209
CREATED:20250813T184042Z
LAST-MODIFIED:20250813T184323Z
UID:1393-1755630000-1755633600@www.rbcconsultants.com
SUMMARY:Unlocking Chronic Spontaneous Urticaria (CSU): Exploring the Role of Bruton’s tyrosine kinase (BTK)
DESCRIPTION:Speaker: Jason Hawkes\, MD\, MS Clinical Assistant Professor of Dermatology\, Oregon Health & Science University Portland\, OR \n  \nModerator: Leon Kircik\, MD\, FAAD Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Adjunct Clinical Professor of Dermatology Indiana University School of Medicine\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another IDEF Educational Series Webinar: Unlocking Chronic Spontaneous Urticaria (CSU): Exploring the Role of Bruton’s tyrosine kinase (BTK) in Pathophysiology\, Unmet Needs\, and Disease Burden. This presentation offers a revealing look at chronic spontaneous urticaria (CSU)\, centered on two key aspects: the role of Bruton’s tyrosine kinase (BTK) as a mediator of FcεRI mast cell degranulation in its pathophysiology\, and the profound impact CSU symptoms can have on patients’ lives. \nREGISTER HERE
URL:https://www.rbcconsultants.com/event/unlocking-chronic-spontaneous-urticaria-csu-exploring-the-role-of-brutons-tyrosine-kinase-btk/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250814T190000
DTEND;TZID=America/New_York:20250814T200000
DTSTAMP:20260415T175209
CREATED:20250805T192236Z
LAST-MODIFIED:20250805T192236Z
UID:1390-1755198000-1755201600@www.rbcconsultants.com
SUMMARY:Transformative Treatment Results in Plaque Psoriasis and Psoriatic Arthritis
DESCRIPTION:Speaker: Marc Serota\, MD Practicing Physician Peak Dermatology Littleton\, CO CEO\, MD Integrations Quadruple Board Certified Dermatology\, Allergy/Asthma/Immunology\, Pediatrics\, and Obesity Medicine\n\n\n\nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY\n\nPlease join us for our next IDEF Educational Series Webinar: Transformative Treatment Results in Plaque Psoriasis and Psoriatic Arthritis.\n\nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/transformative-treatment-results-in-plaque-psoriasis-and-psoriatic-arthritis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250731T190000
DTEND;TZID=America/New_York:20250731T200000
DTSTAMP:20260415T175209
CREATED:20250714T133519Z
LAST-MODIFIED:20250714T133556Z
UID:1385-1753988400-1753992000@www.rbcconsultants.com
SUMMARY:A New Treatment for Adults With Severe Alopecia Areata: LEQSELVI™ (Deuruxolitinib) 8mg
DESCRIPTION:Speaker: Chesahna Kindred\, MD\, MBA\, FAAD Owner and Dermatologist Kindred Hair and Skin \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nPlease join us for our next IDEF Educational Series Webinar: A New Treatment for Adults With Severe Alopecia Areata: LEQSELVI™ (Deuruxolitinib) 8mg — Full Speed A Head.
URL:https://www.rbcconsultants.com/event/a-new-treatment-for-adults-with-severe-alopecia-areata-leqselvi-deuruxolitinib-8mg-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250722T190000
DTEND;TZID=America/New_York:20250722T200000
DTSTAMP:20260415T175209
CREATED:20250714T145503Z
LAST-MODIFIED:20250714T145609Z
UID:1387-1753210800-1753214400@www.rbcconsultants.com
SUMMARY:An Option to Choose TREMFYA First
DESCRIPTION:Speaker: Mona Shahriari\, MD Associate Clinical Professor of Dermatology\, Yale University Associate Director of Clinical Trials\, CCD Research \nModerator: Leon Kircik\, MD\, FAAD Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Adjunct Clinical Professor of Dermatology Indiana University School of Medicine\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another IDEF Educational Series Webinar: An Option to Choose TREMFYA First.
URL:https://www.rbcconsultants.com/event/an-option-to-choose-tremfya-first/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250715T200000
DTEND;TZID=America/New_York:20250715T210000
DTSTAMP:20260415T175209
CREATED:20250617T123649Z
LAST-MODIFIED:20250617T123649Z
UID:1379-1752609600-1752613200@www.rbcconsultants.com
SUMMARY:Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway
DESCRIPTION:Speaker: Lisa Swanson\, MD Pediatric Dermatologist Ada West Dermatology \nJoin us for another International Dermatology Education Foundation Series Webinar: Mild to Moderate Atopic Dermatitis: Burden of Disease and a Topical Pathway. This is an educational program brought to you by Incyte Dermatology. Webinar Objectives: – Review the evolving understanding of atopic dermatitis (AD)\, diagnosis\, management\, and the patient journey – Evaluate a treatment option for mild to moderate AD – Understand the indicated patient population for treatment \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nCLICK HERE TO REGISTER \n 
URL:https://www.rbcconsultants.com/event/mild-to-moderate-atopic-dermatitis-burden-of-disease-and-a-topical-pathway/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250626T190000
DTEND;TZID=America/New_York:20250626T200000
DTSTAMP:20260415T175209
CREATED:20250624T131909Z
LAST-MODIFIED:20250624T131909Z
UID:1382-1750964400-1750968000@www.rbcconsultants.com
SUMMARY:A New Treatment for Adults With Severe Alopecia Areata: LEQSELVI™ (Deuruxolitinib) 8mg
DESCRIPTION:Speaker: Natasha Atanaskova Mesinkovska\, MD\, PhD Vice Chair Dermatology Clinical Research University of California Irvine \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/a-new-treatment-for-adults-with-severe-alopecia-areata-leqselvi-deuruxolitinib-8mg/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250623T190000
DTEND;TZID=America/New_York:20250623T200000
DTSTAMP:20260415T175209
CREATED:20250529T162405Z
LAST-MODIFIED:20250609T124956Z
UID:1375-1750705200-1750708800@www.rbcconsultants.com
SUMMARY:The First Triple-Combination Topical for Acne ⏤ Breaking Ground in Treatment
DESCRIPTION:Speaker: Seemal Desai\, MD\, FAAD Founder & Medical Director Innovative Dermatology Clinical Associate Professor Department of Dermatology Universoty of Texas Southwestern Medical Center \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nAttendees will have the opportunity to pose questions to the speaker about the data presented. This program is sponsored by Ortho Dermatologics and is being presented consistent with FDA guidelines and is not approved for continuing education credit. \nJoin us for another IDEF Educational Series Webinar: The First Triple-Combination Topical for Acne ⏤ Breaking Ground in Treatment. \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/the-first-triple-combination-topical-for-acne-%e2%8f%a4-breaking-ground-in-treatment/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250610T190000
DTEND;TZID=America/New_York:20250610T200000
DTSTAMP:20260415T175209
CREATED:20250529T162159Z
LAST-MODIFIED:20250529T162159Z
UID:1373-1749582000-1749585600@www.rbcconsultants.com
SUMMARY:Getting Started: The Lilly & EBGLYSS™ (lebrikizumab-lbkz) Support Experience
DESCRIPTION:Speaker: DeNae Norman Biotechnology Professional Pharmacy Technician \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nThis program will provide a tailored overview of Lilly Support Services for EBGLYSS and how to get patients started on EBGLYSS\, with a focus on access\, enrollment\, and quick start treatment processes. \nPlease join us for our next IDEF Educational Series Webinar: Getting Started: The Lilly & EBGLYSS™ (lebrikizumab-lbkz) Support Experience. \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/getting-started-the-lilly-ebglyss-lebrikizumab-lbkz-support-experience/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250605T213000
DTEND;TZID=America/New_York:20250605T223000
DTSTAMP:20260415T175209
CREATED:20250529T015417Z
LAST-MODIFIED:20250529T125023Z
UID:1363-1749159000-1749162600@www.rbcconsultants.com
SUMMARY:Vitiligo: Achieving and Maintaining Repigmentation
DESCRIPTION:Speaker: \nSeemal Desai\, MD\, FAAD Innovative Dermatology The University of Texas Southwestern Medical Center Plano\, Texas \n\nWebinar Objectives:  \n– Review clinical features of vitiligo\, disease prevalence\, treatment considerations\, and the patient experience \n– Discuss the mechanism of action and formulation for a topical treatment option for nonsegmental vitiligo \n– Evaluate the safety and efficacy data for a topical treatment option in the treatment of nonsegmental vitiligo \n  \nModerator: \nLeon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nJoin us for another International Dermatology Education Foundation Series Webinar: Vitiligo: Achieving and Maintaining Repigmentation. This is an educational program brought to you by Incyte Dermatology. \n  \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/vitiligo-achieving-and-maintaining-repigmentation/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250603T190000
DTEND;TZID=America/New_York:20250603T200000
DTSTAMP:20260415T175209
CREATED:20250529T161858Z
LAST-MODIFIED:20250529T161858Z
UID:1371-1748977200-1748980800@www.rbcconsultants.com
SUMMARY:Clinical Data and Patient Photos on an Oral Treatment Option for Adults with Plaque Psoriasis
DESCRIPTION:Speaker: Raj Chovatiya\, MD\, PhD\, MSCI\, FAAD Clinical Associate Professor Rosalind Franklin University Chicago Medical School Founder and Director Center for Medical Dermatology + Immunology Research Chicago\, Illinois \nThe program will provide an up-to-date overview with data through 5 years\, including in patients with scalp involvement\, safety data\, and dosing and administration. This event is sponsored by Bristol Myers Squibb\, and the speaker is a paid consultant of Bristol Myers Squibb. This is not a congress-endorsed event and is not part of official programming for a congress. No CME credits will be given for attendance. \nModerator: Leon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \n  \nPlease join us for a discussion that focuses on an oral treatment option for adults with moderate-to-severe plaque psoriasis. \n  \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/clinical-data-and-patient-photos-on-an-oral-treatment-option-for-adults-with-plaque-psoriasis/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250529T190000
DTEND;TZID=America/New_York:20250529T200000
DTSTAMP:20260415T175209
CREATED:20250529T013741Z
LAST-MODIFIED:20250529T125114Z
UID:1359-1748545200-1748548800@www.rbcconsultants.com
SUMMARY:Clinical Updates for WINLEVI (clascoterone) Cream 1%
DESCRIPTION:Speaker: Hilary E. Baldwin\, MD\, FAAD The Acne Treatment and Research Center Rutgers Robert Wood Johnson Medical Center New York\, New York \n  \nDr. Baldwin will review updated data on WINLEVI® (clascoterone) Cream 1%. New data will include the effect WINLEVI has on the skin barrier\, a consideration when selecting a therapeutic approach for your patients. \nModerator:  \nLeon Kircik\, MD\, FAAD President\, International Dermatology Education Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai\, New York\, NY Indiana University Medical Center\, Indianapolis\, IN Medical Director Physicians Skin Care\, PLLC\, Louisville\, KY DermResearch\, PLLC\, Louisville\, KY Skin Sciences\, PLLC\, Louisville\, KY \nJoin us for another International Dermatology Education Foundation Series Webinar: Clinical Updates for WINLEVI® (clascoterone) Cream 1%. \nCLICK HERE TO REGISTER
URL:https://www.rbcconsultants.com/event/clinical-updates-for-winlevi-clascoterone-cream-1/
END:VEVENT
END:VCALENDAR